本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Dianthus Therapeutics Inc.

106.20
+2.922.83%
盤後106.200.00000.00%19:30 EDT
成交量:73.28萬
成交額:7,853.88萬
市值:59.40億
市盈率:-25.82
高:109.79
開:106.78
低:105.00
收:103.28
52周最高:117.88
52周最低:32.22
股本:5,593.44萬
流通股本:5,585.01萬
量比:1.15
換手率:1.31%
股息:- -
股息率:- -
每股收益(TTM):-4.1130
每股收益(LYR):-4.2037
淨資產收益率:-26.07%
總資產收益率:-17.69%
市淨率:5.07
市盈率(LYR):-25.26

資料載入中...

2024/12/03

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/22

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/11

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/07

SEC問詢函

Form CORRESP - Correspondence
2024/10/07

SEC問詢函

Form CORRESP - Correspondence
2024/09/16

重要事件披露

Form 8-K - Current report
2024/09/12

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/08

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/28

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/26

SEC問詢函

Form CORRESP - Correspondence